AGTC Announces Preclinical Data Evaluating Cone-Specific Promoters for Use in Gene Therapy of Achromatopsia and Other Retinal Diseases
January 07, 2016 07:01 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of...
AGTC and BCM Families Foundation Announce Collaboration to Develop AAV-Based Gene Therapy for Blue Cone Monochromacy
January 06, 2016 07:01 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and JUPITER, Fla. and CAMBRIDGE, Mass., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human...
AGTC Leadership to Present at Upcoming Scientific Conferences
January 05, 2016 07:01 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of...
AGTC Added to NASDAQ Biotechnology Index
December 15, 2015 16:41 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Dec. 15, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of...
AGTC and Synpromics Limited Announce R&D Collaboration to Develop Synthetic Promoters for Enhanced Gene Therapy Candidates
December 09, 2015 07:01 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., CAMBRIDGE, Mass. and EDINBURGH, Scotland, Dec. 9, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical...
AGTC CEO to Present at Piper Jaffray Healthcare Conference on December 1, 2015
November 30, 2015 16:14 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of...
AGTC Announces U.S. FDA Orphan Drug Designation for Gene Therapy to Treat Achromatopsia
November 23, 2015 07:01 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 23, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of...
AGTC Wins SEBIO Award for Strategic Deal of the Year
November 18, 2015 07:01 ET
|
Applied Genetic Technologies Corporation
CHARLESTON, S.C., GAINESVILLE, Fla., and CAMBRIDGE, Mass., Nov. 18, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical...
AGTC CEO to Present at Stifel Healthcare Conference on November 18, 2015
November 11, 2015 16:05 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 11, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of...
AGTC Leadership to Present at Upcoming Scientific Conferences
November 09, 2015 07:01 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Nov. 9, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of...